KJ
Insider selling
Khurram Jamil sold $2K of Galectin Therapeutics Inc (GALT) stock
Khurram Jamil, Chief Medical Officer of Galectin Therapeutics Inc (GALT), sold 568 shares of GALT stock worth $2K, per an SEC Form 4 filed May 28, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 26, 2026, 2 days before it was made public.
GALT has moved +41.9% since the trade date, from $2.79 to $3.96 (Sep 21, 2026 close).
- Traded
- May 26, 2026
- Disclosed
- May 28, 2026
- Filing delay
- 2 days
- Price since
- +41.9%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More GALT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.